About Index Trending news
Analyze
Pricing
Relmada Therapeutics

Relmada Therapeutics

Work at Relmada Therapeutics? Add yourself to this profile

Relmada Therapeutics

Relmada (OTCQB: $RLMD) is focused on developing novel versions of proven drug products together with new chemical entities for the treatment of chronic pain.
Edit Profile
More info

Elsewhere

Also headquartered in New York

Verizon Verizon IBM IBM HBO HBO Kickstarter Kickstarter Wired Wired AOL AOL Tumblr Tumblr Time Warner Time Warner Vine Vine BuzzFeed BuzzFeed

Companies in the same industry

MedAvail MedAvail BioNano Genomics BioNano Genomics Cerevast Cerevast EffRx EffRx Bikanta Bikanta GrayBug GrayBug Pulmatrix Pulmatrix Pennington Biomedical Research Center Pennington Biomedical Research Center AmnioChor AmnioChor LUMA D.A.C. LUMA D.A.C.

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
Venture capital
$15,051,110
Venture capital (Series A)
$3,000,000
Employees

Team size

10+
Locations
Unknown
Help us complete this profile

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Relmada Therapeutics makes some noise.